Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-10-21
1993-10-05
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546101, 564428, 548578, C07D22114, C07D295073, A61K 3144
Patent
active
052505391
ABSTRACT:
The invention relates to 1,2,3,4,5,6-hexahydrobenzo[f]quinolin-3-ones, pharmaceutical formulations containing those compounds, and their use as steroid 5.alpha.-reductase inhibitors.
REFERENCES:
patent: 4511569 (1985-04-01), Smith et al.
patent: 4749791 (1988-06-01), Aschwanden et al.
patent: 4859681 (1989-08-01), Rasmusson
patent: 4888336 (1989-12-01), Holt
patent: 5120742 (1992-06-01), Rasmusson
patent: 5120840 (1992-06-01), Weintraub
Horii I, Chem Abs 62, 10405b (1964).
Horii II, Chem Abs 61, 14635h (1964).
Kadohama, Cancer Research 44, 4947 (1984).
Holt, J. Med Chem 33, 943 (1990).
Kadohama, AACH Abstracts, Mar. 1984, vol. 25, p. 209.
Brooks, The Prostate 9, 65 (1986).
Huggins, Cancer Res 1, 293 (1941).
Imperato-McGinley, Science, 186, 1213 (1974).
Andriole, The Prostate 10, 189-197 (1987).
Rittmaster, J. Clin Endrocrine & Metal 65, p. 188 (1987).
Bruchovsky, J. Biol. Chem 243, 2012 (1968).
Itami, J. Investigative Dermatol. 94, 150 (1990).
Hamilton, American J. Anat. 71, 451 (1972).
Takayasu, J. Clin. Endrocin Metab 34, 1098 (1972).
Bingham, J. Endrocrin 57, 111 (1973).
Mooradian, Endocrine Reviews 8, 1 (1972).
Hay, J. Endrocrin. 79, 29 9 (1978).
Rassmusson, J. Med Chem 29, 2298 (1986).
Stinson, Chem & Erg News Jun. 29, 1992 p. 7.
Lamberigts, J. Clin. Endocrin 48, 924 (1979).
ATCC Catalogue of Cell Liens, 1988, p. 159.
Metcalf, Trends in Pharm. Sci 10, 1989, p. 491.
Moore, J. Biol. Chem 251, 5895 (1976).
Moore J. Biol. Chem 250, 7168 (1975).
Leshin, J. Clin. Inves. 62, 503 (1978).
Williams, "Textbook of Endrocrinolog",6th Edition (1981) 1080-1098.
Brooks Endocrinology, 109, 830 (1981).
Wenderoth, Endocrinology 113, 569 (1983).
Schweikert, J. Clin Endocrinol Metal 79, 29 (1978).
Wilson, J. Clin. Investigation 48, p. 371 (1969).
Bach et al., J. Med. Chem., 23, 812-814 (1980).
Cannon et al., J. Med. Chem., 22, 341-347 (1979).
Cannon et al., J. Med. Chem., 23, 1-5 (1980).
Cannon et al., J. Med. Chem., 19, 987-993 (1976).
Cannon et al., J. Med. Chem., 29, 2529-2534 (1986).
Cannon et al., J. Med. Chem., 27, 190-195 (1984).
Wikstrom et al., J. Med. Chem., 25, 925-931 (1982).
Cannon et al., J. Pharm. Sci., 74, 672-675 (1985).
Kiguchi et al., Heterocycles, 18, 217-220 (1982).
Ninomiya et al., J. Chem. Soc., Perkin Trans 1, 2967-2971 (1983).
Ninomiya et al., J. Chem. Soc., Perkin Trans 1, 2911-2917 (1984).
Cannon et al., Synthesis, 6, 494-496 (1986).
Horii et al., Chem. Pharm. Bull., 16, 668-671 (1968).
Horii et al., Chem Pharm. Bull., 1227-1236 (1966).
Costall et al., J. Pharm. Pharmacol., 34, 246-254 (1982).
Petrow, The Prostate, 9:343-361, published by Alan R. Liss, Inc. (1986).
Kadohama et al., 75th Annual Meeting of AACR, Abstracts, vol. 25, 827 (1984).
Petrow et al., J. Pharm. Pharmacol. 36:352-353 (1984).
Hirsch Kenneth S.
Jones Charles D.
Berch Mark L.
Demeter John C.
Eli Lilly and Company
Jones Joseph A.
Whitaker Leroy
LandOfFree
Hexahydrobenzo[f]quinolinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hexahydrobenzo[f]quinolinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hexahydrobenzo[f]quinolinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1004052